Based on Table 1, vincristine had 19.33- and 23.79-fold resistance in drug-selected cancer cells and gene-transfected cells expressing ABCC1, and similarly, this resistance can be reversed by MK571 at 25 μM. This evidence concerns the gene ABCC1 and cancer.